An error in the spelling of the term hyperparathyroidism in the original version has been corrected online.
Additional information
The online version of the original article can be found at 10.1038/nrd3768
Rights and permissions
About this article
Cite this article
Tse, M. Erratum: Amgen builds secondary hyperparathyroidism pipeline. Nat Rev Drug Discov 11, 579 (2012). https://doi.org/10.1038/nrd3791
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3791
